行情回顾：01.04-01.17 期间，医药生物板块涨幅为1.07%，在所有板块中位列第十五，跑输沪深300 指数3.5 个百分点。从子板块看，01.04-01.17 期间，医疗器械、中药、医药商业和医疗服务涨跌幅分别为5.01%、3.43%、2.22%和1.93%，跑赢整体板块；生物制品和化学制药涨跌幅分别为-0.98%和-2.91%，跑输整体板块。

1．行情回顾 ........................................................................................................................................... 3

1.1 医药生物行情回顾 ····················································································································· 3

1.2 医药生物子板块行情回顾 ········································································································· 3

1.3 医药生物板块估值 ····················································································································· 4

1.4 医药生物板块个股表现 ············································································································· 5

2．行业要闻 ........................................................................................................................................... 5

3．投资建议 ........................................................................................................................................... 7

4．风险提示 ........................................................................................................................................... 7